Product

Indication

Description

Development Stage

Nasteso Testosterone nasal gel

TBS-1

Male Hypogonadism (“Low-T”)

  • Nasal testosterone gel
  • Multi-dose device with convenient simple dosing
  • Compelling safety profile

FDA approval May 2014

Tefina

TBS-2

Female Orgasmic Disorder

  • Nasal testosterone gel
  • “Use as Required” treatment for improving female sexual health

Phase II ambulatory study initiated May 2012.  Top line data provided in May 2014

TriVair

TBS-5
TBS-6
TBS-7


Asthma – Bronchopasm and Maintenance Therapy

 

 

  • On-demand rapid relief
  • Lower drug exposure with immediate visual feedback
  • Improved deposition of active drug and reduced risk of re-infection

Formulation Development

 

Investigational new drug application for bronchospasm treatment approved by FDA in January 2011

Estrace   Symptomatic relief of menopausal symptoms.
  • 17 Beta-estradiol
  • Oral tablets
Market

 

© 2014 by Trimel Pharmaceuticals Corporation